Form 4: Exelixis Director Sue Gail Eckhardt Reports Stock Sales and Option Exercise
SEC Form 4 Filing
Director Sue Gail Eckhardt reports exercising stock options and selling shares of Exelixis, Inc. common stock on February 14, 2025.
Summary
- Sue Gail Eckhardt, a director of Exelixis, Inc., reported transactions involving the company's common stock on February 14, 2025.
- Eckhardt exercised options to purchase 7,712 shares at $23.24 per share.
- She then sold 7,712 shares at a weighted average price of $35.01 and 3,856 shares at a weighted average price of $35.04.
- Following these transactions, Eckhardt directly owns 30,406 shares of common stock that will be issued upon vesting of restricted stock units, and 23,136 shares via options.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, with neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions and provides transparency to the market regarding the trading activities of company directors.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the director's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 01/05/2024 | Option became fully exercisable |
| 02/14/2025 | Date of stock option exercise and sales |
| 01/04/2031 | Expiration date of the option |
| 02/19/2025 | Date of Form 4 filing |
Keywords
Exelixis, Director, Stock Options, Common Stock, Form 4, Eckhardt, Sales, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.